180 related articles for article (PubMed ID: 16267753)
1. Fluconazole prophylaxis for critically ill patients at high risk for Candida infection.
Garbino J
Clin Infect Dis; 2005 Dec; 41(11):1690-1. PubMed ID: 16267753
[No Abstract] [Full Text] [Related]
2. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
Kramer KM; Skaar DJ; Ackerman BH
Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
[TBL] [Abstract][Full Text] [Related]
3. [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
Thomas F; Mebtouche B; Clavier H; Kalfon P
Rev Pneumol Clin; 2000 Feb; 56(1):37-40. PubMed ID: 10740113
[TBL] [Abstract][Full Text] [Related]
4. Inadequate proof of adverse outcome due to the use of fluconazole in critically ill patients.
Blot SI; Hoste EA; Vandewoude KH; Colardyn FA
Arch Surg; 2000 Sep; 135(9):1114. PubMed ID: 10982521
[No Abstract] [Full Text] [Related]
5. Multifocal Candida species colonization as a trigger for early antifungal therapy in critically ill patients: what about other risk factors for fungal infection?
Charles PE
Crit Care Med; 2006 Mar; 34(3):913-4. PubMed ID: 16505683
[No Abstract] [Full Text] [Related]
6. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
[TBL] [Abstract][Full Text] [Related]
7. Treatment of critically ill patients with candidemia.
Mensa J; Pitart C; Marco F
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S93-7. PubMed ID: 19013347
[TBL] [Abstract][Full Text] [Related]
8. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
[TBL] [Abstract][Full Text] [Related]
9. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
10. Timely selection of adequate antifungal therapy for candidemia in the critically ill: don't let the yeast rise!
Corona A; Cislaghi F; Singer M
Crit Care Med; 2008 Nov; 36(11):3097-8. PubMed ID: 18941310
[No Abstract] [Full Text] [Related]
11. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
Garey KW; Rege M; Pai MP; Mingo DE; Suda KJ; Turpin RS; Bearden DT
Clin Infect Dis; 2006 Jul; 43(1):25-31. PubMed ID: 16758414
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological advances in the treatment of invasive candidiasis.
Deck DH; Guglielmo BJ
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
[TBL] [Abstract][Full Text] [Related]
13. The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients.
Magill SS; Swoboda SM; Johnson EA; Merz WG; Pelz RK; Lipsett PA; Hendrix CW
Diagn Microbiol Infect Dis; 2006 Aug; 55(4):293-301. PubMed ID: 16698215
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
Ghannoum MA; Kim HG; Long L
J Antimicrob Chemother; 2007 Mar; 59(3):556-9. PubMed ID: 17242032
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole plus amphotericin B combinations are not contraindicated and may add benefit for the treatment of candidemia.
Odds FC
Clin Infect Dis; 2003 May; 36(10):1229-31. PubMed ID: 12746766
[No Abstract] [Full Text] [Related]
16. Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.
Garey KW; Neuhauser MM; Bearden DT; Cannon JP; Lewis RE; Gentry LO; Kontoyiannis DP
Mycoses; 2006 May; 49(3):226-31. PubMed ID: 16681815
[TBL] [Abstract][Full Text] [Related]
17. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
[TBL] [Abstract][Full Text] [Related]
18. To treat or not to treat--critically ill patients with candiduria.
Hollenbach E
Mycoses; 2008 Sep; 51 Suppl 2():12-24. PubMed ID: 18721329
[TBL] [Abstract][Full Text] [Related]
19. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
20. Candida famata fungemia in a surgical patient successfully treated with fluconazole.
Carrega G; Riccio G; Santoriello L; Pasqualini M; Pellicci R
Eur J Clin Microbiol Infect Dis; 1997 Sep; 16(9):698-9. PubMed ID: 9352267
[No Abstract] [Full Text] [Related]
[Next] [New Search]
